These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 7549058
1. Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels. Ramos EL, Barri YM, Kubilis P, Peterson JC, Pfaff WW, Howard RJ, Parris CJ, Patton PR, Karlix JL. Clin Transplant; 1995 Jun; 9(3 Pt 1):185-9. PubMed ID: 7549058 [Abstract] [Full Text] [Related]
2. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients. Ahmadi F, Naseri R, Lessan-Pezeshki M. Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470 [Abstract] [Full Text] [Related]
3. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center. Tinawi M, Miller L, Bastani B. Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686 [Abstract] [Full Text] [Related]
4. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA. Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259 [Abstract] [Full Text] [Related]
6. C2 monitoring in maintenance renal transplant recipients: is it worthwhile? Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T. Transplantation; 2003 Oct 27; 76(8):1236-8. PubMed ID: 14578761 [Abstract] [Full Text] [Related]
7. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy. Tang SC, Chan KW, Tang CS, Lam MF, Leung CY, Tse KC, Li CS, Ho YW, Tong MK, Lai KN, Chan TM, Hong Kong Nephrology Study Group. Nephrol Dial Transplant; 2006 Nov 27; 21(11):3243-51. PubMed ID: 16877482 [Abstract] [Full Text] [Related]
8. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients. Schweiger M, Wasler A, Prenner G, Stiegler P, Stadlbauer V, Schwarz M, Tscheliessnigg K. Transpl Immunol; 2006 Jun 27; 16(1):46-51. PubMed ID: 16701176 [Abstract] [Full Text] [Related]
9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group. Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208 [Abstract] [Full Text] [Related]
10. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients. Nawaz SH, Zafar MN, Naqvi SA, Rizvi SA. J Pak Med Assoc; 2005 Mar 27; 55(3):98-100. PubMed ID: 15852743 [Abstract] [Full Text] [Related]
11. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice. Sabbagh F, El Tawil Z, Lecerf F, Hulin A, Maurois P, Dartevelle P, Bac P, German-Fattal M. Transplantation; 2008 Aug 15; 86(3):436-44. PubMed ID: 18698248 [Abstract] [Full Text] [Related]
13. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Holzmacher R, Kendziorski C, Michael Hofman R, Jaffery J, Becker B, Djamali A. Nephrol Dial Transplant; 2005 Jul 15; 20(7):1456-62. PubMed ID: 15840674 [Abstract] [Full Text] [Related]
14. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine. Hilbrands LB, Hoitsma AG, Wetzels JF, Koene RA. Clin Nephrol; 1996 Apr 15; 45(4):230-5. PubMed ID: 8861797 [Abstract] [Full Text] [Related]
16. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation. Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R. Transplant Proc; 2005 Oct 15; 37(8):3354-7. PubMed ID: 16298594 [Abstract] [Full Text] [Related]
17. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation. Min DI, Perry PJ, Chen HY, Hunsicker LG. Pharmacotherapy; 1998 Oct 15; 18(2):282-7. PubMed ID: 9545147 [Abstract] [Full Text] [Related]
18. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients. Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ. Clin Transplant; 1998 Dec 15; 12(6):553-6. PubMed ID: 9850449 [Abstract] [Full Text] [Related]
19. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL. Clin Transplant; 1994 Aug 15; 8(4):388-95. PubMed ID: 7949545 [Abstract] [Full Text] [Related]
20. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients. Chang HR, Lin CC, Lian JD. Transplant Proc; 2007 Dec 15; 39(10):3135-41. PubMed ID: 18089339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]